Compare Stocks

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.04 -41.7%	C$0.03	C$0.02 ▼ C$0.12	C$770K	N/A	20,281 shs	1,000 shs
MTFB MOTIF BIO PLC/S	$0.11	$0.10	$0.08 ▼ $11.50	N/A	N/A	N/A	867,698 shs
PBS Invesco Next Gen Media and Gaming ETF	$42.06 -2.2%	$41.91	$30.95 ▼ $40.10	$30.29M	1.38	5,287 shs	994 shs
VAL Valaris	$69.82 -1.4%	$68.98	$54.13 ▼ $78.92	$5.06B	1.13	911,272 shs	421,810 shs

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COT Cotinga Pharmaceuticals Inc. (COT.V)	0.00%	0.00%	0.00%	0.00%	0.00%
MTFB MOTIF BIO PLC/S	0.00%	0.00%	0.00%	0.00%	0.00%
PBS Invesco Next Gen Media and Gaming ETF	-23.15%	0.00%	-22.78%	-13.50%	-5.32%
VAL Valaris	-1.43%	-3.85%	-1.36%	+7.05%	+5.80%

Elon Musk’s ChatGPT Could Soon Mint New Millionaires (Ad)

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VAL Valaris	3.5118 of 5 stars	3.5	2.0	0.0	0.0	2.7	1.7	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	0.00	N/A	$46.45	10.44% Upside
VAL Valaris	3.00	Buy	$100.00	43.23% Upside

Current Analyst Ratings

Latest MTFB, PBS, COT, PEBI, and VAL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/5/2024	VAL Valaris	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$105.00 ➝ $102.00
2/23/2024	VAL Valaris	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$107.00 ➝ $105.00
2/14/2024	VAL Valaris	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$106.00 ➝ $105.00

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	C$0.00 per share	17.50	C($0.18) per share	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A	N/A	N/A	N/A
VAL Valaris	$1.78B	2.83	$2.49 per share	28.05	$27.40 per share	2.55

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	-C$0.12	N/A	∞	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	33.44	∞	N/A	N/A	N/A	N/A	N/A
VAL Valaris	$865.40M	$11.69	5.97	6.73	N/A	48.50%	5.71%	2.40%	5/2/2024 (Confirmed)

Latest MTFB, PBS, COT, PEBI, and VAL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/2/2024	N/A	VAL Valaris	$0.40	N/A	-$0.40	N/A	N/A	N/A
2/21/2024	Q4 2023	VAL Valaris	$0.29	$0.61	+$0.32	-$10.08	$484.00 million	$483.80 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.24	685.71%	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	$0.25	0.59%	N/A	N/A	N/A
VAL Valaris	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	0.05	0.01
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A	N/A	N/A
VAL Valaris	0.54	1.71	1.71

Ownership

Institutional Ownership

Company	Institutional Ownership
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A
VAL Valaris	96.74%

Insider Ownership

Company	Insider Ownership
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A
PBS Invesco Next Gen Media and Gaming ETF	N/A
VAL Valaris	0.11%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	21.99 million	N/A	Not Optionable
MTFB MOTIF BIO PLC/S	7	N/A	N/A	Not Optionable
PBS Invesco Next Gen Media and Gaming ETF	N/A	720,000	N/A	Not Optionable
VAL Valaris	5,985	72.41 million	72.33 million	Optionable

MTFB, PBS, COT, PEBI, and VAL Headlines

Source	Headline
	Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL) marketbeat.com - April 14 at 6:11 AM
	Valaris Schedules First Quarter 2024 Earnings Release and Conference Call businesswire.com - April 11 at 4:30 PM
	Aramco Suspends Valaris Rig Contract rigzone.com - April 11 at 1:38 AM
	Valaris (VAL) Receives Rig's Suspension Notice From Aramco zacks.com - April 9 at 2:26 PM
	Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL) marketbeat.com - April 9 at 12:12 PM
	Port Everglades marks commissioning of new container cranes en.portnews.ru - April 7 at 11:30 AM
	Valaris faces rig suspension in Saudi joint venture investing.com - April 6 at 2:41 AM
	Aramco Suspends Another Jack-Up Rig oedigital.com - April 5 at 4:40 PM
	Suspension notice for Valaris joint venture royalgazette.com - April 5 at 4:40 PM
	Saudi Aramco suspends offshore rig deal with New York-listed player upstreamonline.com - April 5 at 1:44 AM
	Aramco suspends jackup contract with offshore driller upstreamonline.com - April 4 at 8:43 PM
	Valaris (NYSE:VAL) Shares Gap Down to $76.66 marketbeat.com - April 4 at 2:02 PM
	Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc. marketbeat.com - April 3 at 4:09 AM
	Valaris: Buy Despite Near-Term Jackup Market Headwinds seekingalpha.com - April 2 at 7:31 PM
	VAL Quantitative Stock Analysis nasdaq.com - April 1 at 6:26 PM
	Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - April 1 at 4:14 AM
	Four-way race in heated Petrobras tender for well intervention vessels upstreamonline.com - March 28 at 4:58 PM
	Esgian Week 12 Report: New Finds in Guyana, China and Norway marinelink.com - March 24 at 9:59 PM
	Wellington Management Group LLP Purchases 107,008 Shares of Valaris Limited (NYSE:VAL) marketbeat.com - March 20 at 4:39 AM
	Activists Across 6 Countries Stage Day of Action Against North Sea Oil Drilling truthout.org - March 17 at 2:06 PM
	'North Sea Fossil Free': Activists in 6 Countries Protest 'Unhinged' Oil and Gas Development commondreams.org - March 16 at 10:22 PM
	DNB Asset Management AS Cuts Holdings in Valaris Limited (NYSE:VAL) marketbeat.com - March 16 at 6:53 AM
	'Scaling innovation': Offshore players invest in carbon capture, efficiency and electrification upgrades upstreamonline.com - March 13 at 5:44 PM
	Perenco Starts Gas Production in Southern North Sea oedigital.com - March 11 at 5:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cotinga Pharmaceuticals Inc. (COT.V)

CVE:COT

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

MOTIF BIO PLC/S

NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Invesco Next Gen Media and Gaming ETF

NYSEARCA:PBS

PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Valaris

NYSE:VAL

Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial